MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 535094 | Name: FLA 21

Description:

WARNING: This product is for research use only, not for human or veterinary use.

FLA 21 is a bioactive chemical.

Chemical Structure

FLA 21
FLA 21
CAS#611-56-3

Theoretical Analysis

MedKoo Cat#: 535094

Name: FLA 21

CAS#: 611-56-3

Chemical Formula: C24H28N2O4

Exact Mass: 408.2049

Molecular Weight: 408.50

Elemental Analysis: C, 70.57; H, 6.91; N, 6.86; O, 15.67

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
FLA 21; FLA-21; FLA21
IUPAC/Chemical Name
Acetamide, N-(3-(diethylamino)propyl)-2-((4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy)-
InChi Key
INZKDTCOKBTCIH-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H28N2O4/c1-3-26(4-2)14-8-13-25-24(28)17-29-19-11-12-20-21(27)16-22(30-23(20)15-19)18-9-6-5-7-10-18/h5-7,9-12,15-16H,3-4,8,13-14,17H2,1-2H3,(H,25,28)
SMILES Code
O=C(NCCCN(CC)CC)COC1=CC=C2C(C=C(C3=CC=CC=C3)OC2=C1)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 408.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Smeds MR, Duncan AA, Harlander-Locke MP, Lawrence PF, Lyden S, Fatima J, Eskandari MK; Vascular Low-Frequency Disease Consortium. Treatment and outcomes of aortic endograft infection. J Vasc Surg. 2016 Feb;63(2):332-40. doi: 10.1016/j.jvs.2015.08.113. PMID: 26804214. 2: Farmer JR, Foldvari Z, Ujhazi B, De Ravin SS, Chen K, Bleesing JJH, Schuetz C, Al-Herz W, Abraham RS, Joshi AY, Costa-Carvalho BT, Buchbinder D, Booth C, Reiff A, Ferguson PJ, Aghamohammadi A, Abolhassani H, Puck JM, Adeli M, Cancrini C, Palma P, Bertaina A, Locatelli F, Di Matteo G, Geha RS, Kanariou MG, Lycopoulou L, Tzanoudaki M, Sleasman JW, Parikh S, Pinero G, Fischer BM, Dbaibo G, Unal E, Patiroglu T, Karakukcu M, Al-Saad KK, Dilley MA, Pai SY, Dutmer CM, Gelfand EW, Geier CB, Eibl MM, Wolf HM, Henderson LA, Hazen MM, Bonfim C, Wolska-Kuśnierz B, Butte MJ, Hernandez JD, Nicholas SK, Stepensky P, Chandrakasan S, Miano M, Westermann-Clark E, Goda V, Kriván G, Holland SM, Fadugba O, Henrickson SE, Ozen A, Karakoc-Aydiner E, Baris S, Kiykim A, Bredius R, Hoeger B, Boztug K, Pashchenko O, Neven B, Moshous D, Villartay JP, Bousfiha AA, Hill HR, Notarangelo LD, Walter JE. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1970-1985.e4. doi: 10.1016/j.jaip.2019.02.038. Epub 2019 Mar 12. PMID: 30877075; PMCID: PMC6612449. 3: Son A, O'Donnell TF Jr, Izhakoff J, Gaebler JA, Niecko T, Iafrati MA. Lymphedema-associated comorbidities and treatment gap. J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):724-730. doi: 10.1016/j.jvsv.2019.02.015. Epub 2019 Jun 24. PMID: 31248833. 4: Ahmed SA, Guerrero Flórez M, Karanis P. The impact of water crises and climate changes on the transmission of protozoan parasites in Africa. Pathog Glob Health. 2018 Sep;112(6):281-293. doi: 10.1080/20477724.2018.1523778. Epub 2018 Oct 17. PMID: 30332341; PMCID: PMC6381522. 5: Allen KB, Chhatriwalla AK, Saxon JT, Cohen DJ, Nguyen TC, Webb J, Loyalka P, Bavry AA, Rovin JD, Whisenant B, Dvir D, Kennedy KF, Thourani V, Lee R; Bioprosthetic Valve Fracture Investigators. Bioprosthetic valve fracture: Technical insights from a multicenter study. J Thorac Cardiovasc Surg. 2019 Nov;158(5):1317-1328.e1. doi: 10.1016/j.jtcvs.2019.01.073. Epub 2019 Jan 31. PMID: 30857820. 6: Ganzer R, Arthanareeswaran VKA, Ahmed HU, Cestari A, Rischmann P, Salomon G, Teber D, Liatsikos E, Stolzenburg JU, Barret E. Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):175-186. doi: 10.1038/s41391-018-0042-0. Epub 2018 May 9. PMID: 29743538. 7: Yuan L, Li W, Huo Q, Du C, Wang Z, Yi B, Wang M. Effects of xylo- oligosaccharide and flavomycin on the immune function of broiler chickens. PeerJ. 2018 Mar 5;6:e4435. doi: 10.7717/peerj.4435. PMID: 29527412; PMCID: PMC5842763. 8: Walser E, Nance A, Ynalvez L, Yong S, Aoughsten JS, Eyzaguirre EJ, Williams SB. Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease. J Vasc Interv Radiol. 2019 Mar;30(3):401-409.e2. doi: 10.1016/j.jvir.2018.09.016. PMID: 30819483. 9: Wood DL, Sawicki GS, Miller MD, Smotherman C, Lukens-Bull K, Livingood WC, Ferris M, Kraemer DF. The Transition Readiness Assessment Questionnaire (TRAQ): its factor structure, reliability, and validity. Acad Pediatr. 2014 Jul- Aug;14(4):415-22. doi: 10.1016/j.acap.2014.03.008. PMID: 24976354. 10: Lala S, Scali ST, Feezor RJ, Chandrekashar S, Giles KA, Fatima J, Berceli SA, Back MR, Huber TS, Beaver TM, Beck AW. Outcomes of thoracic endovascular aortic repair in adult coarctation patients. J Vasc Surg. 2018 Feb;67(2):369-381.e2. doi: 10.1016/j.jvs.2017.06.103. Epub 2017 Sep 22. PMID: 28947226. 11: Gonçalves DS, Ferreira MDS, Gomes KX, Rodríguez-de La Noval C, Liedke SC, da Costa GCV, Albuquerque P, Cortines JR, Saramago Peralta RH, Peralta JM, Casadevall A, Guimarães AJ. Unravelling the interactions of the environmental host Acanthamoeba castellanii with fungi through the recognition by mannose- binding proteins. Cell Microbiol. 2019 Oct;21(10):e13066. doi: 10.1111/cmi.13066. Epub 2019 Jun 19. PMID: 31173452. 12: Sanchez-Alvarez C, Mertz LE, Thomas CS, Cochuyt JJ, Abril A. Demographic, Clinical, and Radiologic Characteristics of a Cohort of Patients with Takayasu Arteritis. Am J Med. 2019 May;132(5):647-651. doi: 10.1016/j.amjmed.2018.12.017. Epub 2019 Jan 4. PMID: 30615861. 13: Najdenski H, Heyndrickx M, Herman L, Messens W. Fla-DGGE analysis of Campylobacter jejuni and Campylobacter coli in cecal samples of broilers without cultivation. Vet Microbiol. 2008 Feb 5;127(1-2):196-202. doi: 10.1016/j.vetmic.2007.08.002. Epub 2007 Aug 15. PMID: 17890022. 14: Sulaiman TA, Delgado AJ, Donovan TE. Survival rate of lithium disilicate restorations at 4 years: A retrospective study. J Prosthet Dent. 2015 Sep;114(3):364-6. doi: 10.1016/j.prosdent.2015.04.011. Epub 2015 Jun 3. PMID: 26050028. 15: Lu X, Jorge Forte A, Sawh-Martinez R, Wu R, Cabrejo R, Steinbacher DM, Alperovich M, Alonso N, Persing JA. Association of Regional Cranial Base Deformity and Ultimate Structure in Crouzon Syndrome. Plast Reconstr Surg. 2019 Jun;143(6):1233e-1243e. doi: 10.1097/PRS.0000000000005643. PMID: 31136487. 16: Giles KA, Scali ST, Pearce BJ, Huber TS, Berceli SA, Arnaoutakis DJ, Back MR, Fatima J, Upchurch GR Jr, Beck AW. Impact of secondary interventions on mortality after fenestrated branched endovascular aortic aneurysm repair. J Vasc Surg. 2019 Dec;70(6):1737-1746.e1. doi: 10.1016/j.jvs.2019.02.029. Epub 2019 Aug 13. PMID: 31420254. 17: Moradi A, Allen S, Bank D, Marmur E, Fagien S, Glaser DA, Maguire C, Cohen JL. A Prospective, Multicenter, Randomized, Evaluator-Blinded, Split-Hand Study to Evaluate the Effectiveness and Safety of Large-Gel-Particle Hyaluronic Acid with Lidocaine for the Correction of Volume Deficits in the Dorsal Hand. Plast Reconstr Surg. 2019 Oct;144(4):586e-596e. doi: 10.1097/PRS.0000000000006070. PMID: 31568288; PMCID: PMC6766356. 18: Moreno-Mesonero L, Moreno Y, Alonso JL, Ferrús MA. Detection of viable Helicobacter pylori inside free-living amoebae in wastewater and drinking water samples from Eastern Spain. Environ Microbiol. 2017 Oct;19(10):4103-4112. doi: 10.1111/1462-2920.13856. Epub 2017 Aug 15. PMID: 28707344. 19: Moreno-Mesonero L, Hortelano I, Moreno Y, Ferrús MA. Evidence of viable Helicobacter pylori and other bacteria of public health interest associated with free-living amoebae in lettuce samples by next generation sequencing and other molecular techniques. Int J Food Microbiol. 2020 Apr 2;318:108477. doi: 10.1016/j.ijfoodmicro.2019.108477. Epub 2019 Dec 12. PMID: 31855786. 20: O'Donnell TFX, Deery SE, Boitano LT, Siracuse JJ, Schermerhorn ML, Scali ST, Schanzer A, Lancaster RT, Patel VI. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J Vasc Surg. 2019 Feb;69(2):414-422. doi: 10.1016/j.jvs.2018.04.050. Epub 2018 Jun 28. PMID: 30686337.